Patrick Campbell is the managing editor of HCPLive. Formerly the editorial lead of Endocrinology Network, Practical Cardiology, and Rheumatology Network, Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. He now helps to lead coverage in each of these respective areas for HCPLive. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.
ACC/AHA 2017 Exercise Recommendations May Not Be Enough to Prevent Hypertension
April 19th 2021An analysis of the CARDIA study by investigators at UCSF suggests a recommendation of 5 hours of physical activity per week may be more appropriate than the current ACC/AHA recommendation for reducing the risk of hypertension.
Read More
Dapagliflozin Effective for Reducing CV Risk in Diabetes, Irrespective of Kidney Function
April 16th 2021TIMI Group investigators found the effects of dapagliflozin on cardiovascular risk in patients with diabetes were comparable in those with markers of CKD and those without markers of CKD at baseline.
Read More
Inadequate Response to Arthritis Therapy Could Signal Increased Risk of Heart Attack
April 16th 2021An analysis of medical data from a major database in Taiwan suggests an inadequate response to DMARD therapy among patients with rheumatoid arthritis was associated with increased risk of acute coronary syndrome.
Read More
Race, Gender, & Income Influence Access to SGLT2 Inhibitors Among US Patients
April 15th 2021Using data from nearly 1 million patients with type 2 diabetes in a commercial database, investigators provide a comprehensive of the impact race/ethnicity, gender, and income can have on the likelihood of receiving a prescription for SGLT2 inhibitors.
Read More
Study Finds Risk of Kidney Stones Increases During and Immediately After Pregnancy
April 15th 2021An analysis of nearly 3k women from a single county in Minnesota suggests pregnancy was associated with an increased risk of kidney stones and results provide insight into when this apparent risk peaks and subsides.
Read More
Low-Intensity Walking Program Fails to Show Benefit for Peripheral Artery Disease
April 14th 2021A trial led by clinicians from Northwestern Medicine suggests the presence of ischemic leg symptoms could serve as a useful indicator for patients to help determine whether they will see a meaningful benefit from their walking program.
Read More
CLARIFY: Diabetes Poses Major Risk in Patients with Coronary Syndromes
April 13th 2021An analysis of the CLARIFY registry is providing clinicians with further insight into the impact of diabetes in patients with chronic coronary syndromes, particularly the increased risk of stroke, myocardial infarction, and cardiovascular death.
Read More
Preterm Birth Associated with Increased Heart Failure Risk Throughout Adulthood
April 9th 2021An analysis of nearly 4.2 million patients from a birth registry indicates being born preterm was linked to a significantly higher risk of developing heart failure during childhood and a 42% greater risk of heart failure in adulthood.
Read More
Disparities in Failure to Rescue Rates Drives Racial Differences in Maternal Mortality
April 9th 2021While data indicates care has improved, a retrospective study from investigators at Columbia University suggests differences in rates of failure to rescue from severe maternal morbidity were a major contributor to the disparity in excess maternal mortality seen among Black women.
Read More
Stem Cells Show Promise for Nonhealing Diabetic Foot Ulcers in Phase 1 Trial
April 8th 2021New data suggest injections of adipose-derived SVF cells could elicit wound closure in patients with nonhealing diabetic foot ulcers and, subsequently, reduce the need for amputation in this patient population.
Read More
LITE Trial: Low-Intensity Walking Provides Little to No Benefit for PAD Patients
April 8th 2021Results of a 305-patient trial indicate ischemic leg pain could serve as a threshold for whether or not a patient with peripheral artery disease will see a meaningful improvement in walking score from their walking routine.
Read More
Neuropathy Contributes, But Not Entirely Responsible for Fracture Risk in Type 1 Diabetes
April 7th 2021A case-controlled study of 60 patients in the United Kingdom found presence neuropathy contributes to fracture risk in patients with type 1 diabetes but found other factors play a role in the increased risk among these patients.
Read More
Implementation and Use of Patient-Reported Outcomes in Heart Failure with Stephen Greene, MD
April 7th 2021Hear from Stephen Greene, MD, as he takes a deeper dive into a recent study he led comparing use of NYHA class vs. KCCQ-OS to capture changes in disease state among patients with heart failure with reduced ejection fraction.
Read More
Transition to Telemedicine Practices May Have Streamlined Care in Cardiology Clinics
April 7th 2021An analysis of data from Cedars-Sinai medical centers suggests the shift to telemedicine during the pandemic led to a reduction in a number of diagnostic tests and medications prescribed when compared to rates of both during the pre-pandemic era.
Read More
Future Therapies in Lipidology
April 7th 2021In this portion of the panel discussion, panelists examine newer therapies for the treatment of lipid disorders. Included in this section are brief discussions around icosapent ethyl, inclisiran, and bempedoic acid. *This conversation occurred in February 2021 and regulatory approvals/decisions may have changed since filming.
Read More
Heart Failure Risk Among Children Born Preterm Persists Through Adulthood
April 6th 2021An analysis of more than 4 million singleton births indicates children born at an early gestational age were at an increased risk of heart failure at multiple points throughout life when compared to their counterparts not considered preterm births.
Read More
High-Frequency Spinal Cord Stimulation Could Offer Hope in Refractory Diabetic Neuropathy
April 6th 2021Results of a randomized clinical trial suggest treatment with high-frequency spinal cord stimulation added to conventional medical management could lead to pain relief and improvements in quality of life among patients with refractory peripheral diabetic neuropathy.
Read More
Study Calls for Change in Prescribing Practices of Antihypertensive Agents in Patients with HIV
April 6th 2021An analysis of more than 8000 patients with HIV and hypertension suggests these patients may not be receiving the most efficacious antihypertensive agents and this could be placing these patients at increased risk of cardiovascular disease events or death.
Read More
Welcome to Inside Cardiology: Lipid Management 2021. This edition of Inside Cardiology features a discussion around lipidology led by Chief of Practical Cardiology's Editorial Advisory Board Guy Mintz, MD. Mintz is joined by fellow advisory board members Lucia Novak, CRNP, and Brett Nowlan, MD. In the first segment, panelists introduce themselves and examine the first case report in their 5-part discussion.
Read More